KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Change in Receivables (2016 - 2025)

Charles River Laboratories International has reported Change in Receivables over the past 17 years, most recently at -$27.6 million for Q4 2025.

  • Quarterly results put Change in Receivables at -$27.6 million for Q4 2025, down 734.27% from a year ago — trailing twelve months through Dec 2025 was -$35.7 million (down 65.36% YoY), and the annual figure for FY2025 was -$35.7 million, down 65.36%.
  • Change in Receivables for Q4 2025 was -$27.6 million at Charles River Laboratories International, down from -$26.6 million in the prior quarter.
  • Over the last five years, Change in Receivables for CRL hit a ceiling of $59.7 million in Q2 2022 and a floor of -$27.6 million in Q4 2025.
  • Median Change in Receivables over the past 5 years was $3.8 million (2021), compared with a mean of $7.7 million.
  • Biggest five-year swings in Change in Receivables: soared 1135.05% in 2022 and later tumbled 734.27% in 2025.
  • Charles River Laboratories International's Change in Receivables stood at -$9.0 million in 2021, then plummeted by 163.41% to -$23.6 million in 2022, then fell by 8.68% to -$25.6 million in 2023, then skyrocketed by 87.09% to -$3.3 million in 2024, then tumbled by 734.27% to -$27.6 million in 2025.
  • The last three reported values for Change in Receivables were -$27.6 million (Q4 2025), -$26.6 million (Q3 2025), and -$10.9 million (Q2 2025) per Business Quant data.